Pharmaceuticals

Somatic Genetic Testing Market Forecast 2026–2035: Data Trends and Industry Insights

February 18, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the somatic genetic testing market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Somatic Genetic Testing Market size between 2026 and 2035?

The somatic genetic testing market has seen a rapid expansion in its size recently. This market is set to expand from $7.78 billion in 2025 to $8.88 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.1%. In the past, this growth was influenced by factors including restricted accessibility to genetic testing, a reliance on traditional diagnostic approaches, an increasing understanding of somatic mutations in cancer, the development of hospital and clinical laboratory infrastructure, and increased funding directed towards research institutions.

The somatic genetic testing market is projected to experience substantial expansion in the coming years, with its valuation expected to reach $14.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.9%. This anticipated growth during the forecast period is fueled by several factors, including developments in NGS and multi-omics technologies, the broadening availability of at-home and clinical sequencing services, the proliferation of precision medicine efforts, increased government investment in genetic testing programs, and the incorporation of AI-based analytics for interpreting mutations. Key developments expected over this period encompass a greater uptake of targeted gene panels for both cancer and rare diseases, a wider application of next-generation sequencing (NGS) technologies, the progression of personalized and precision oncology treatments, the wider availability of at-home genetic testing options, and the integration of multi-omics data into clinical decision-making processes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

Which Drivers Are Impacting Market Performance In The Somatic Genetic Testing Market?

The rising occurrence of cancer is projected to drive the expansion of the somatic genetic testing market in the future. Cancer encompasses various illnesses defined by the unchecked proliferation and dissemination of atypical cells within the body. This growing burden of cancer stems from lifestyle factors like an unhealthy diet, tobacco use, lack of physical activity, and heavy alcohol intake. Somatic genetic testing assists in diagnosing cancer through the identification of genetic mutations specific to tumors, thereby facilitating tailored and individualized treatment strategies. By leveraging sophisticated technologies, it reduces the need for invasive procedures, enhancing both diagnostic precision and patient results. For example, in November 2023, the Canadian Cancer Society, a national cancer agency based in Canada, indicated that an estimated 239,100 Canadians are anticipated to receive a cancer diagnosis in 2023, with roughly 86,700 expected to succumb to the illness. Consequently, the escalating rate of cancer incidence is fueling the expansion of the somatic genetic testing market.

Which Segments Are Contributing To The Growth Of The Somatic Genetic Testing Market?

The somatic genetic testing market covered in this report is segmented –

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Which Trends Are Influencing The Development Of The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are focusing on developing advanced diagnostic solutions, such as liquid biopsy tests, to enhance accuracy, enable early detection, and reduce the need for invasive procedures. Liquid biopsy tests refer to non-invasive methods that analyze circulating tumor DNA (ctDNA) or other biomarkers in blood samples to detect cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-generation liquid biopsy designed to identify circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test engineered to discover somatic mutations across 74 key cancer-related genes. This test assists in personalized cancer treatment by pinpointing actionable mutations, monitoring therapeutic responses, and detecting minimal residual disease (MRD) without needing traditional tissue biopsies. It further supports precision oncology, helping guide targeted therapies and track disease progression or resistance in real-time.

Who Are The Core Companies Influencing Trends In The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

Which Regions Are Projected To Dominate The Somatic Genetic Testing Market In The Coming Years?

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Somatic Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp

Browse Through More Reports Similar to the Global Somatic Genetic Testing Market 2026, By The Business Research Company

Smart Workplace Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-workplace-global-market-report

Office Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/office-automation-global-market-report

Smart Windows Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-windows-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795